Journal of Bone and Joint Infection (Sep 2018)

Prolonged Cefoxitin Infusion Using Mobile Elastomeric Infusors In Outpatients With Bone And Joint Infection

  • Z. Cavalli,
  • Z. Cavalli,
  • A. Becker,
  • A. Becker,
  • A. Becker,
  • A. Bosch,
  • A. Bosch,
  • A. Bosch,
  • A. Conrad,
  • A. Conrad,
  • A. Conrad,
  • C. Triffault-Filit,
  • C. Triffault-Filit,
  • C. Triffault-Filit,
  • F. Valour,
  • F. Valour,
  • F. Valour,
  • F. Valour,
  • F. Laurent,
  • F. Laurent,
  • F. Laurent,
  • F. Laurent,
  • S. Cohen,
  • C. Chidiac,
  • C. Chidiac,
  • C. Chidiac,
  • T. Ferry,
  • T. Ferry,
  • T. Ferry,
  • T. Ferry

DOI
https://doi.org/10.7150/jbji.27718
Journal volume & issue
Vol. 3
pp. 182 – 186

Abstract

Read online

We reviewed all outpatients with bone and joint infection treated with cefoxitin in continuous intravenous infusion using mobile elastomeric infusors in our regional reference center between 2014 and 2017. The stability of cefoxitin provides an interesting and well-tolerated alternative for continuous infusion in outpatients with polymicrobial bone and joint infection.